Vitamin J — Competitive Intelligence Brief

Vitamin J (Choline) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Central Nervous System Stimulant [EPC]. Area: Neuroscience.

marketed Central Nervous System Stimulant [EPC] Neuroscience Small molecule

Target snapshot

Vitamin J (Choline) — University of Colorado, Denver.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Vitamin J TARGET	Choline	University of Colorado, Denver	marketed	Central Nervous System Stimulant [EPC]
Vyvanse	LISDEXAMFETAMINE	Takeda	marketed	Central Nervous System Stimulant	Sodium-dependent dopamine transporter	2007-01-01
Focalin	DEXMETHYLPHENIDATE	Novartis	marketed	Central Nervous System Stimulant	Sodium-dependent dopamine transporter	2001-01-01
DIHYDROCODEINE BITARTRATE	DIHYDROCODEINE BITARTRATE		marketed	Central Nervous System Stimulant [EPC]		1983-01-01
PYRILAMINE MALEATE	PYRILAMINE MALEATE		marketed	Central Nervous System Stimulant [EPC]		1973-01-01
Pyrilamine	mepyramine	Impax Labs	marketed	Central Nervous System Stimulant [EPC]	Histamine H1 receptor	1973-01-01
PYRILAMINE	PYRILAMINE		marketed	Central Nervous System Stimulant [EPC]		1973-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Central Nervous System Stimulant [EPC] class)

1. · 5 drugs in this class
2. Caraco · 1 drug in this class
3. Hikma · 1 drug in this class
4. Impax Labs · 1 drug in this class
5. Second Affiliated Hospital, School of Medicine, Zhejiang University · 1 drug in this class
6. UCB · 1 drug in this class
7. University of Colorado, Denver · 1 drug in this class